Plasma metabolic profiling reveals exploratory metabolic differences in chronic coronary syndrome with coronary artery calcification
Frontiers in Cardiovascular Medicine · 26.06.2026 · 13
DOI: 10.3389/fcvm.2026.1741496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 26.06.2026. Verfasst von Xiaoxue Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/objectives Coronary artery calcification (CAC) is a specific marker of coronary atherosclerotic heart disease, with chronic coronary syndrome (CCS) being a primary clinical manifestation of coronary artery disease. However, research on the plasma metabolites of individuals with CCS and CAC, as well as the identification of candidate markers is scarce. Here we aimed to explore metabolic differences among CAC patients, CCS patients, and healthy controls.
Methods
We conducted a study involving 30 patients with CCS (CCS group), 30 with CAC (CAC group), and 30 healthy controls (Control group). Plasma parameters were statistically analyzed. Moreover, metabolomics analysis explored the composition and functions of metabolites in the plasma of each group.
Results
We found that serum creatinine and fasting glucose levels were significantly increased in the CAC group, whereas blood urea nitrogen levels were significantly higher in both the CAC and CCS groups compared with Control group. Significant metabolic differences were observed between the CCS and CAC groups. Further analyses indicated that oleic acid and arachidonic acid were among the metabolites contributing to the separation between CAC patients and healthy controls.
Conclusion
These findings suggest that plasma metabolite profiles differ among the study groups. The identified metabolites may contribute to distinguishing CAC patients from those with CCS as well as healthy controls, providing additional insights into the metabolic alterations associated with these conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
- Department of Cardiovascular Medicine, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
- Faculty of Life Science and Biotechnology, Kunming University of Science and Technology, Kunming, Yunnan, China.
Zitieren
APA
Ding, X., Wu, H., Pang, M., Liu, S., Chen, H., Zhuang, K., Su, W., Zhao, Y., & Zhang, H. (2026). Plasma metabolic profiling reveals exploratory metabolic differences in chronic coronary syndrome with coronary artery calcification. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1741496
Vancouver
Ding X, Wu H, Pang M, Liu S, Chen H, Zhuang K, et al. Plasma metabolic profiling reveals exploratory metabolic differences in chronic coronary syndrome with coronary artery calcification. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1741496
BibTeX
@article{Ding2026,
author = {Ding, Xiaoxue and Wu, Haiyan and Pang, Mingjie and Liu, Shiqi and Chen, Haoqiang and Zhuang, Ke and Su, Wenhua and Zhao, Yan and Zhang, Hong},
title = {Plasma metabolic profiling reveals exploratory metabolic differences in chronic coronary syndrome with coronary artery calcification},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1741496}
}
EUVIMED